Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CLPSL1, or colipase-like protein 1, is classified as a "colipase-like" gene product, and also referred to as C6orf127 in the human genome. It is part of a gene family related by sequence to canonical colipase, which is a small (~10-12 kDa) protein crucial as a cofactor for pancreatic triglyceride lipase activity. However, CLPSL1 does not have a characterized function, no known physiological or pathological role, and is not considered a therapeutic or druggable target. Current scientific literature does not provide clarity on whether CLPSL1 is expressed as a functional protein or has any roles similar to colipase (CLPS). The confusion likely stems from the naming similarity to canonical colipase (CLPS), which is a well-characterized lipase cofactor necessary for dietary lipid digestion. However, CLPSL1/colipase-like protein 1 is not characterized to have such a function and is not currently a recognized biological or pharmacological target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Colipase-like protein 1 (CLPSL1).